Kyrgyzstan Eyes Tobacco Tax Hikes as Core Strategy to Curb Smoking

Jun.11.2025
Kyrgyzstan Eyes Tobacco Tax Hikes as Core Strategy to Curb Smoking
Kyrgyz health authorities and WHO experts urge stronger tobacco taxation to curb smoking and ease the economic impact of noncommunicable diseases.

Key Highlights:

 

·Kyrgyzstan held a meeting to discuss increasing tobacco taxes in order to reduce tobacco and nicotine consumption. 

 

·Approximately 6,000 Kyrgyzstani people aged 30 and above die from tobacco-related diseases each year. 

 

·The economic losses from cardiovascular diseases caused by tobacco consumption amount to as high as 1.7 billion som (19.43 million USD) annually.

 


 

According to K-News on June 10th, a conference with the theme "Effective Approaches to Reduce Tobacco and Nicotine Consumption: Simulated Tax Models in the Kyrgyz Republic" was held in the capital city of Bishkek, Kyrgyzstan. The conference was organized by the Public Health and Mass Communication Center of Kyrgyzstan in collaboration with the World Health Organization (WHO) Country Office and the WHO Framework Convention on Tobacco Control Knowledge Hub, aiming to reduce the accessibility of tobacco products through effective tax policies.

 

Kyrgyzstan's Minister of Health, Erkin Checheibayev, pointed out during a meeting that raising tobacco consumption taxes is crucial for improving public health nationwide, especially for the younger generation.

 

According to estimates from the WHO, in Kyrgyzstan, tobacco-related diseases lead to the deaths of over 6,000 people aged 30 and above each year, including around 5,000 men and 1,000 women. Additionally, despite national tobacco control policies, the economic burden of tobacco-related cardiovascular diseases exceeds 1.7 billion som (19.43 million USD).

 

Data shows that in Kyrgyzstan, 30% of men aged 35 to 69 die from tobacco consumption, compared to 5% of women in the same age group, leading to a decrease in average lifespan by 21 years. Multiple studies by the World Health Organization indicate that raising the prices of tobacco products and implementing taxes is the most effective measure to reduce tobacco and nicotine consumption, as it makes these products unaffordable for young people.

 

Furthermore, economic research indicates that increasing taxes can raise the prices of tobacco products and decrease the consumption rates of tobacco among both adults and youth. For example, in developing countries, when the actual price of cigarettes increases by 10%, the number of children and adolescents who smoke decreases by 8%.

 

An analysis of the economic burden of non-communicable diseases (NCDs) in 2015 showed that Kyrgyzstan suffered overall economic losses (indirect costs) of 1.71 billion som (19.49 million USD) annually, equivalent to 3.9% of the country's GDP. Health care expenses for treating four types of NCDs accounted for one fifth of the direct costs. More than half of the losses were due to premature death, resulting in an economic loss of 1.04 billion som (11.85 million USD). The cost of policy measures to control tobacco use was 0.14 billion som (150,000 USD), while the cost of interventions for cardiovascular diseases and diabetes amounted to 17.5 billion som (100 million USD).

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
As the FDA advances efforts to streamline its PMTA review process, including support for small businesses, expectations are rising that additional product authorizations may follow. Age-verification technology is emerging as a key consideration in future approvals.In this interview, California-based Glas discusses its G2 platform, integrating smartphone-based identity verification, proximity controls and anti-counterfeit systems, and outlines its positioning under the FDA’s PMTA framework.
Mar.02
Kumulus Vape launches Labster production unit for e-liquids and DIY concentrates
Kumulus Vape launches Labster production unit for e-liquids and DIY concentrates
Kumulus Vape has launched Labster, a 700 sq m production unit in the Lyon Metropolis near the group’s headquarters, for e-liquids and DIY concentrates. The site is equipped with automated lines supplied by CDA (Constructions d’Automatismes) to carry out bottling and labeling. Its theoretical capacity is described as several million bottles per year in 10–100 ml formats, and it is already operational.
Feb.06 by 2FIRSTS.ai
VCU Signs Letter of Intent to Buy Altria Building for USD 150 Million, Pending State Approval
VCU Signs Letter of Intent to Buy Altria Building for USD 150 Million, Pending State Approval
Virginia Commonwealth University has signed a letter of intent to acquire Altria Group’s 450,000-square-foot building in downtown Richmond for USD 150 million, but the deal still depends on approval from the General Assembly. The university said the facility would support expansion of the Massey Comprehensive Cancer Center and help grow enrollment in its new School of Public Health and School of Pharmacy. VCU also said constructing a comparable facility would cost about USD 715 million.
Mar.13 by 2FIRSTS.ai
Austria to Tighten Sales Rules for Nicotine Pouches and E-Liquids From April 1
Austria to Tighten Sales Rules for Nicotine Pouches and E-Liquids From April 1
Austria will introduce new sales rules for nicotine products from April 1, 2026. Under a reform of the tobacco law passed in December 2025, nicotine pouches will in future be sold only through tobacco shops, while e-liquids will be sold only through tobacco shops and licensed specialist stores. Other points of sale will no longer be permitted to sell these products.
Mar.30 by 2FIRSTS.ai
Philippine Customs Seizes Illegal Vape Products Worth Up to PHP 1.4 Billion in Navotas Warehouse
Philippine Customs Seizes Illegal Vape Products Worth Up to PHP 1.4 Billion in Navotas Warehouse
The Philippine Bureau of Customs seized illegal vape products worth an estimated PHP 1 billion to PHP 1.4 billion at a warehouse in Navotas City. Customs Commissioner Ariel Nepomuceno said the operation was the agency’s largest crackdown on illegal vape products since 2024.
Mar.23 by 2FIRSTS.ai
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
A cross-sectional analysis based on the US NHANES 2021–2023 cycle, including 6,262 participants aged over 12, found that compared with people who neither smoke nor vape, those who smoke and/or use e-cigarettes had a higher prevalence of elevated blood pressure and hypertension. After full adjustment, smoking/vaping was associated with elevated blood pressure (aOR 1.34) and hypertension (aOR 1.46), and with a 1.05 mmHg higher diastolic blood pressure.
Feb.09 by 2FIRSTS.ai